Physostigmine treatment of gamma-hydroxybutyric acid overdose: appropriate or inappropriate use of a reversal agent?
Dean
W
W
D000328:Adult; D000368:Aged; D000777:Anesthetics / Q000009:adverse effects*; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006885:Hydroxybutyrates / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010830:Physostigmine / Q000009:adverse effects / Q000627:therapeutic use*
D000777:Anesthetics; D002800:Cholinesterase Inhibitors; D006885:Hydroxybutyrates; C111420:4-hydroxybutyric acid; D010830:Physostigmine